IP/patents and a robust product pipeline, including instruments and implants which improve bone graft delivery to the inter-vertebral space, integrate cage placement and graft delivery to reduce procedure steps and simplify spinal fusion surgery overall.

The company's first commercially available product, a Bi-Directional Graft Funnel (KG™ 1), works with any viscosity of biologic graft material, provides a more efficient and safer delivery vehicle for bone graft extenders, facilitates grafting in front of or alongside all types of inter-body cages and can eliminate or reduce surgeon dependency on BMP.

The (KG™ 2) Solid State Fusion Cage simplifies and standardizes bone graft delivery by utilizing our patented "flow-through" technology, integrating cage implantation and bone graft delivery to effectively reduce steps, OR time, and the potential for operative complications in MIS Fusion Surgery. The (KG™ 2) was submitted for 510(k) clearance to the FDA in 2021, with anticipated approval in Q3 of 2021. The (KG™ 2) does not have 510(k) clearance at this time.

The Endplate Preparation System (DragonTail™) offers a unique, single pass instrument that allows a 120 degree arc of endplate preparation and multiple tip options that allows increased access to the contra-lateral disk space. Development is nearing the FDA submission phase sometime in Q4 of 2021. The (DragonTail™) does not have 510(k) clearance at this time.

Additional IP surrounding instruments and implants are part of the company's patent portfolio, and further down the product development pipeline.